Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912599 · ClinicalTrials.gov registry record · NA
Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma
A NA study of Normal-Tension Glaucoma, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT01912599: Completed NA study of Normal-Tension Glaucoma, sponsored by University of North Carolina, Chapel Hill.
NCT01912599 is a NA study of Normal-Tension Glaucoma that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01912599, a NA study of Normal-Tension Glaucoma, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Purpose: To study the feasibility of a larger study by determining the tolerability of measuring blood pressure (BP) and intraocular pressure (IOP) over 24 hours in an ambulatory fashion with automatic devices. Participants: 20 patients with moderate to severe normal tension glaucoma and 20 non-glaucomatous patients. Procedures (methods): Both BP and IOP will be measured automatically in each participant in an ambulatory fashion during a 24-hour period. BP will be monitored using an appropriately sized cuff Oscar 2 (Suntech Medical, Morrisville, NC), which will be placed by a person trained in ambulatory BP monitoring devices. The device will be set up to automatically inflate every 30 minutes during the day and every hour during the night to measure and record the BP. IOP will be measured using Sensimed Triggerfish contact lens (Sensimed AG, Lausanne, Switzerland); the measurements will be taken and recorded every 10 minutes. The contact lens will be inserted by eye doctors (investigators). Both monitoring devices will be removed the following day.
Primary Outcome
The blood pressure value shown in the table is the mean of all measurements taken over the 24 hour period, so it is the average value.
Conditions Studied
Interventions
- DEVICE Sensimed Triggerfish
- DEVICE Blood Pressure
Study Locations (1)
North Carolina
- UNC Kittner Eye Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01912599 record still lists
NCT01912599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Normal-Tension Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Sensimed Triggerfish is the first listed.
NCT01912599 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01912599 about?
NCT01912599 is a clinical study titled "Pilot Study on Ambulatory Intraocular Pressure and Blood Pressure Monitoring in Glaucoma". Purpose: To study the feasibility of a larger study by determining the tolerability of measuring blood pressure (BP) and intraocular pressure (IOP) over 24 hours in an ambulatory fashion with automatic devices. Participants: 20 patients with moderate to severe normal tension glaucoma and 20 non-gla...
What is the current status of trial NCT01912599?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2013-07. Estimated completion is 2014-07.
What conditions does trial NCT01912599 study?
This clinical trial studies the following conditions: Normal-Tension Glaucoma.
What interventions are being tested in trial NCT01912599?
The interventions under investigation include: Sensimed Triggerfish (DEVICE), Blood Pressure (DEVICE).
Who is sponsoring clinical trial NCT01912599?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01912599 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01912599's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia